产品名称：Human SLAMF7 Antibody (Elotuzumab, Research Use)
产品编号：NBR-0084
针对靶点：SLAMF7
抗体药商品名：Elotuzumab
抗体药描述：Elotuzumab, sold under the brand name Empliciti, is a humanized IgG1 monoclonal antibody medication used in combination with lenalidomide and dexamethasone, for adults that have received 1 to 3 prior therapies for the treatment of multiple myeloma. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: SLAMF7
Synonyms: CRACC; CS1; CD319; 19A
Target Description: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo-or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.
Ensembl: ENSG00000026751
Uniprot:  Q9NQ25